Date published: 2025-11-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr649 Inhibitors

Olr649 inhibitors are a class of chemical compounds specifically designed to interact with and inhibit the activity of the Olr649 receptor, a member of the olfactory receptor family. Olfactory receptors, primarily known for their role in the detection of odor molecules, are G-protein-coupled receptors (GPCRs) embedded in the cell membranes of olfactory neurons. The Olr649 receptor, like others in its class, is characterized by a seven-transmembrane domain structure, which allows it to transduce extracellular signals through intracellular G-proteins, initiating a cascade of cellular responses. The inhibition of Olr649 is achieved through the binding of these inhibitors to the receptor, which either blocks the binding site for natural ligands or induces a conformational change that prevents signal transduction. This interaction can be highly specific, depending on the molecular structure of the inhibitor, which is designed to fit precisely into the receptor's binding site, thereby ensuring effective inhibition.

The development and study of Olr649 inhibitors involve a multidisciplinary approach, encompassing molecular biology, chemistry, and biophysics. Researchers employ various techniques to design these inhibitors, including computational modeling, structure-activity relationship (SAR) studies, and high-throughput screening of compound libraries. The efficacy of these inhibitors is often evaluated through in vitro assays, where their binding affinity and inhibitory potency are measured. Advanced techniques like X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are utilized to elucidate the detailed binding interactions between Olr649 inhibitors and the receptor, providing insights into the molecular basis of inhibition. Additionally, the study of Olr649 inhibitors contributes to a broader understanding of GPCR function and regulation, highlighting the intricate mechanisms by which these receptors control cellular responses. This research can pave the way for the development of more selective and potent inhibitors, enhancing our ability to manipulate olfactory receptor activity for scientific exploration.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

mTOR inhibitor, potentially disrupting proteins involved in cell growth and proliferation pathways.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Inhibits Src family kinases, potentially influencing proteins in cell signaling pathways.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Proteasome inhibitor, potentially impacting protein degradation and cell cycle regulation.

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

Dual inhibitor of EGFR and HER2, potentially disrupting proteins in associated signaling pathways.

Neratinib

698387-09-6sc-364549
sc-364549A
sc-364549B
sc-364549C
sc-364549D
5 mg
25 mg
100 mg
500 mg
1 g
$90.00
$210.00
$375.00
$740.00
$1225.00
4
(1)

EGFR and HER2 inhibitor, potentially affecting proteins in these signaling pathways.

CH5424802

1256580-46-7sc-364461
sc-364461A
5 mg
50 mg
$191.00
$902.00
(0)

ALK inhibitor, potentially affecting proteins in ALK-driven signaling pathways.

Cobimetinib

934660-93-2sc-507421
5 mg
$270.00
(0)

MEK inhibitor, potentially affecting proteins in the MAPK/ERK pathway.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Inhibits multiple kinases, potentially disrupting proteins in cell signaling and growth pathways.